Search Results - "Figenschau, Y."

Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial by Jorde, R., Sneve, M., Figenschau, Y., Svartberg, J., Waterloo, K.

“… Objectives.  The objective of the present study was to examine the cross‐sectional relation between serum 25‐hydoxyvitamin D [25‐(OH) D] levels and…”
Get full text

High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile by Jorde, R, Figenschau, Y, Hutchinson, M, Emaus, N, Grimnes, G

“…Background/Objectives: Low serum 25-hydroxyvitamin D (25(OH)D) concentrations are related to increased mortality. One possible explanation could be an…”
Get full text

Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects by Sneve, M, Figenschau, Y, Jorde, R

“…ObjectiveInvestigate whether cholecalciferol supplementation leads to weight loss in overweight and obese adults.DesignRandomized double blind clinical trial…”
Get full text

Serum lipid levels in relation to serum thyroid‐stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study by IQBAL, A., JORDE, R., FIGENSCHAU, Y.

“… Objective.  To evaluate the relation between serum thyroid‐stimulating hormone (TSH) and lipids. Design.  Cross‐sectional epidemiological study, nested…”
Get full text

Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up by Grimnes, G., Emaus, N., Joakimsen, R. M., Figenschau, Y., Jenssen, T., Njølstad, I., Schirmer, H., Jorde, R.

“…Diabet. Med. 27, 1107–1115 (2010) Aims  We wanted to test the hypothesis that low serum 25‐hydroxyvitamin D (25(OH)D) concentrations are associated with…”
Get full text

The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial by Grimnes, G., Joakimsen, R., Figenschau, Y., Torjesen, P. A., Almås, B., Jorde, R.

“…Summary Vitamin D is widely used in osteoporosis treatment, although the optimal dose is not known. This 1-year clinical study among 297 women aged 50–80 years…”
Get full text

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip by Svartberg, J, Agledahl, I, Figenschau, Y, Sildnes, T, Waterloo, K, Jorde, R

“…Our intention was to examine if subnormal testosterone levels in older men were associated with a reduction in quality of life and physical and mental health,…”
Get full text

Blood pressure in relation to serum thyrotropin: the Tromsø study by IQBAL, A, FIGENSCHAU, Y, JORDE, R

“…It appears to be an association between hypothyroidism and hypertension. However, the relation between thyroid function and blood pressure within the normal…”
Get full text

Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity by Kamycheva, E, Jorde, R, Figenschau, Y, Haug, E

“…To investigate the relation between secondary hyperparathyroidism (SHPT) and insulin sensitivity, 15 subjects with SHPT (serum PTH >6.4 pmol/l, serum calcium…”
Get full text

Human Articular Chondrocytes Express Functional Leptin Receptors by Figenschau, Yngve, Knutsen, Gunnar, Shahazeydi, Suzan, Johansen, Oddmund, Sveinbjörnsson, Baldur

“…The effects of leptin hormone are mediated by interactions with several physiological regulatory systems and the cytokine network, and by targeting cells…”
Get full text

Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study by Hutchinson, M. S., Joakimsen, R. M., Njølstad, I., Schirmer, H., Figenschau, Y., Jorde, R.

“…Background: Glycated hemoglobin (HbA 1c ) 6.5% has recently been recommended by the World Health Organization (WHO) and the American Diabetes Association (ADA)…”
Get full text

Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromsø study by Jorde, R, Saleh, F, Figenschau, Y, Kamycheva, E, Haug, E, Sundsfjord, J

“…Objective: Smoking is associated with reduced bone density and calcium absorption, and reduced serum levels of vitamin D. A compensatory increase in serum…”
Get full text

Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity by Haugbro, K, Nossent, J C, Winkler, T, Figenschau, Y, Rekvig, O P

“…Background: The presence of “anti-DNA antibodies in abnormal titres” is a well established criterion for SLE classification, but there is no agreement on the…”
Get full text

No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year by Jorde, R., Sneve, M., Torjesen, P., Figenschau, Y.

“…  Jorde R, Sneve M, Torjesen P, Figenschau Y (University of Tromsø, Tromsø; Medical Clinic University Hospital of North Norway, Tromsø; University Hospital of…”
Get full text

Haemostatic function in subjects with mild subclinical hypothyroidism. The Tromsø study by Jorde, R, Figenschau, Y, Hansen, J-B

Get more information

S67-02 Effects of vitamin d supplementation on symptoms of depression in obese subjects: Randomized double blind trial by Jorde, R, Sneve, M, Figenschau, Y, Svartberg, J, Waterloo, K

“…The objective of the present study was to examine the cross-sectional relation between serum 25-hydoxyvitamin D (25(OH)D) levels and depression in obese…”
Get full text

Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro by Pettersen, I, Figenschau, Y, Olsen, E, Bakkelund, W, Smedsröd, B, Sveinbjörnsson, B

“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is produced by immune cells and by mediating apoptosis, TRAIL plays an important role in tumor…”
Get full text

P136 Opioid concept in human articular cartilage and chondrocytes: expression and possible effect in cartilage-damaging states by Andjelkov, N, Elvenes, J, Knutsen, G, Figenschau, Y, Johansen, O

Get full text

G.P.17.05 Creatine kinase (CK) in a normal population: Towards new referent values? by Lilleng, H, Johnsen, S.H, Stensland, E, Abeler, K, Løseth, S, Jorde, R, Figenschau, Y, Lindal, S, Bekkelund, S.I

Get full text

No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D 3 for 1 year by Jorde, R., Sneve, M., Torjesen, P., Figenschau, Y.

“…Jorde R, Sneve M, Torjesen P, Figenschau Y (University of Tromsø, Tromsø; Medical Clinic University Hospital of North Norway, Tromsø; University Hospital of…”
Get full text